Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurobiological Technologies initiates second phase II memantine trial

May 2, 1997

Modafinil for sleep apnea-hypopnea syndrome

May 2, 1997

Positive clinical results for pramipexole in schizophrenia

May 2, 1997

Antioxidants reported by Hoechst Marion Roussel

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

Guidant and Neuroperfusion to further develop device for stroke

April 30, 1997

GABA-B antagonists from Novartis

April 30, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

SKB reports neuronal calcium channel antagonists

April 29, 1997

Sanofi describes selective NK3 receptor antagonists

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...